73 pending office actions • 57 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19040032 | Human Therapeutic Targets and Modulators Thereof | Lifemine Therapeutics, Inc. | HARPER, ELIYAH STONE | 2166 | Non-Final OA | Jan 29, 2025 |
| 18999039 | Surfactant Formulations for Inhalation | Merz Pharmaceuticals, LLC | BECKHARDT, LYNDSEY MARIE | 1613 | Final Rejection | Dec 23, 2024 |
| 18845458 | DEEP ELECTROMAGNETIC REBAR PROBE SYSTEM, AND METHOD OF USING SAME | Atomic Energy Of Canada Limited/Énergie Atomique Du Canada Limitée | RAJAPUTRA, SURESH KS | 2858 | Non-Final OA | Sep 10, 2024 |
| 18804359 | Engine Systems and Uses Thereof | Alpha Portfollo LLC | MEADE, LORNE EDWARD | 3741 | Non-Final OA | Aug 14, 2024 |
| 18794626 | Patient Turning Apparatus and Method | Frontier Therapeutics Limited | ORTIZ, ADAM C | 3673 | Non-Final OA | Aug 05, 2024 |
| 18749872 | Systems and Methods for Producing Carbon Solids | Soane Labs, LLC | HERNANDEZ-KENNEY, JOSE | 1717 | Non-Final OA | Jun 21, 2024 |
| 18659478 | Compositions and Methods for Modulating the Intestinal Microbiome | Gelesis, LLC | SWIFT, CANDICE LEE | 1657 | Non-Final OA | May 09, 2024 |
| 18697847 | Use Of Epoxidized Vegetable Oils As Tanning Agents | Workem S.r.l. Unipersonale | SINGH-PANDEY, ARTI R | 1759 | Non-Final OA | Apr 02, 2024 |
| 18587048 | Fused Heterotetracyclic Antiviral Agents | Enanta Pharmaceuticals, Inc. | HEASLEY, MEGHAN CHRISTINE | 1626 | Non-Final OA | Feb 26, 2024 |
| 18582877 | Fused Heterobicyclic Antiviral Agents | Enanta Pharmaceuticals, Inc. | REILLY, SOPHIA JANE | 1627 | Non-Final OA | Feb 21, 2024 |
| 18422936 | Sulfated Glycosaminoglycan Biomaterials as Proteoglycan Mimics | Glycologix, Inc. | HIBSHMAN, SARAH GRACE | 1693 | Final Rejection | Jan 25, 2024 |
| 18420855 | BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | Enanta Pharmaceuticals, Inc. | YOO, SUN JAE | 1621 | Non-Final OA | Jan 24, 2024 |
| 18580180 | PORTABLE SYSTEM FOR MONITORING AIRBORNE RADIONUCLIDES | Atomic Energy Of Canada Limited/ Énergie Atomique Du Canada Limitée | HO, ALLEN C | 2884 | Non-Final OA | Jan 18, 2024 |
| 18413954 | Bioconversion of Short-Chain Hydrocarbons to Fuels and Chemicals | Ramon Gonzalez | SINGH, SATYENDRA K | 1657 | Non-Final OA | Jan 16, 2024 |
| 18578921 | Phytase Variants | AB Enzymes OY | MARTIN, RACHEL E | 1657 | Non-Final OA | Jan 12, 2024 |
| 18406738 | CARBOXYLIC ACID PLATFORM FOR FUEL AND CHEMICAL PRODUCTION AT HIGH CARBON AND ENERGY EFFICIENCY | Mojia Biotech Pte. Ltd. | STANKOVIC, BRATISLAV | 1662 | Non-Final OA | Jan 08, 2024 |
| 18390287 | Covalent Inhibitors As Antiviral Agents | Enanta Pharmaceuticals, Inc. | GONZALEZ, LUISALBERTO | 1624 | Non-Final OA | Dec 20, 2023 |
| 18569713 | Complexes Of CU(I) As Antitumor Agents | UNIVERSITA DEGLI STUDI DI PADOVA | CHANDRAKUMAR, NIZAL S | 1625 | Non-Final OA | Dec 13, 2023 |
| 18533351 | NOVEL PARTICLE COMPOSITION COMPRISING SIALIC ACID BINDING LIGAND | Cytodigm, Inc. | NGUYEN, NGOC-ANH THI | 1615 | Non-Final OA | Dec 08, 2023 |
| 18565247 | USE OF ISTRADEFILLIN TO REDUCE ORGAN FIBROSIS | Sunnutrapharma S.r.l. | MCKOY, QUINCY ANDRE | 1626 | Non-Final OA | Nov 29, 2023 |
| 18516274 | Pan-Cancer Classification Based on FMRP Pathway Activity that Informs Differential Prognosis and Therapeutic Responses | ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE | KIM, YOUNG J | 1681 | Non-Final OA | Nov 21, 2023 |
| 18509403 | MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS | Enanta Pharmaceuticals, Inc. | TAO, BIN | 1625 | Non-Final OA | Nov 15, 2023 |
| 18505538 | COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR | Opna Bio SA | ROBINSON, MIKHAIL O'DONNEL | 1627 | Non-Final OA | Nov 09, 2023 |
| 18387577 | Use Of 2-Phenyl-6-(1H-Imidazol-1-YL) Quinazoline For Treating Neurodegenerative Diseases, Preferably Alzheimer's Disease | Rottapharm Biotech S.r.l. | BARSKY, JARED | 1628 | Non-Final OA | Nov 07, 2023 |
| 18015602 | QTY FC Fusion Water Soluble GPCR Proteins | Avalon Globocare Corp. | DUFFY, PATRICIA ANN | 1645 | Non-Final OA | Oct 16, 2023 |
| 18379685 | METHODS AND COMPOSITIONS FOR TREATING LONG COVID-19 | Intrinsic Medicine, Inc. | KRISHNAN, GANAPATHY | 1693 | Non-Final OA | Oct 13, 2023 |
| 18480009 | USE AND DETECTION METHOD OF FLAVIVIRUS PROTEIN MICROARRAY | National Cheng Kung University | CHESTNUT, BARRY A | 1672 | Non-Final OA | Oct 03, 2023 |
| 18375604 | REVERSIBLY PROTECTED COLORANTS AND METHODS OF USE | Kinnos Inc. | COHEN, MICHAEL P | 1612 | Non-Final OA | Oct 02, 2023 |
| 18244882 | ORAL PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING PARTICULATE FORMULATION COMPRISING COMPOSITION | Sunsho Pharmaceutical Co., Ltd. | ARNOLD, ERNST V | 1613 | Final Rejection | Sep 11, 2023 |
| 18280508 | FOOD SUPPLEMENT TO PROMOTE BODY WEIGHT LOSS | Ngn Healthcare-New Generation Nutraceuticals S.r.l. | HOFFMAN, SUSAN COE | 1655 | Non-Final OA | Sep 06, 2023 |
| 18549061 | COMPOUNDS, COMPOSITIONS, AND METHODS OF TREATMENT THEREOF | Lifemine Therapeutics | SHOWALTER, ALEXANDER KEITH | 1629 | Non-Final OA | Sep 05, 2023 |
| 18278499 | APPARATUS AND METHOD FOR MOTION CAPTURE | Yana Health Systems Ltd. (Dba Yana Motion Lab) | WESTFALL, SARAH ANN | 3791 | Non-Final OA | Aug 23, 2023 |
| 18236560 | FUSED HETEROBICYCLIC ANTIVIRAL AGENTS | Enanta Pharmaceuticals, Inc. | REILLY, SOPHIA JANE | 1627 | Non-Final OA | Aug 22, 2023 |
| 18454013 | PEPTIDES AND METHODS OF USING THE SAME | Serpin Pharma, LLC | FISCHER, JOSEPH | 1658 | Non-Final OA | Aug 22, 2023 |
| 18269916 | A Tracer Compound and a Preparation Method Thereof | Turun Yliopisto | KENYON, JOHN S | 1625 | Non-Final OA | Jun 27, 2023 |
| 18212223 | IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE ENHANCEMENT OF ANTI-TUMOR EFFICACY OF IMMUNO-ONCOLOGY AGENTS | Intrinsic Medicine, Inc. | CRAIGO, BAHAR ALAWI | 1699 | Non-Final OA | Jun 21, 2023 |
| 18327321 | ITERATIVE PLATFORM FOR THE SYNTHESIS OF ALPHA FUNCTIONALIZED PRODUCTS | Ramon Gonzalez | HUTSON, RICHARD G | 1652 | Non-Final OA | Jun 01, 2023 |
| 18200747 | METHODS FOR IMPROVING MUSCLE STRENGTH AND MOBILITY | Intrinsic Medicine, Inc. | MILLER, DALE R | 1693 | Non-Final OA | May 23, 2023 |
| 18253653 | ANTI-TUMOUR RESPONSES TO CYTOKERATINS | Scancell Limited | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | Non-Final OA | May 19, 2023 |
| 18253730 | BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF | Dunad Therapeutics Ltd. | HIBBERT, CATHERINE S | 1658 | Non-Final OA | May 19, 2023 |
| 18196080 | NUCLEIC ACID TARGETING PROPROTEIN CONVERTASE SUBTILISIN/KEXIN 9 AND USES THEREOF | SynerK Biotech Limited | ALLEN, SARAH ELIZABETH | 1637 | Non-Final OA | May 11, 2023 |
| 18196097 | NUCLEIC ACID TARGETING ANGIOTENSINOGEN AND USES THEREOF | SynerK Biotech Limited | MCGARRY, SEAN | 1635 | Non-Final OA | May 11, 2023 |
| 18036065 | Multilayer Mono-Material Polyethylene (PE) Assembly And Its Use In Food Packaging | Di Mauro Officine Grafiche S.p.A. | PLESZCZYNSKA, JOANNA | 1783 | Non-Final OA | May 09, 2023 |
| 18035623 | PHOTOSTABLE COMPOSITION | Ndg Natural Development Group S.r.l. | BROWE, DAVID | 1617 | Non-Final OA | May 05, 2023 |
| 18032023 | A Purified Extract Isolated from Agrimonia Coreana Nakai Containing Abundant Amount of Active Ingredient, the Preparation Thereof, the Composition Comprising the Same as an Active Ingredient for Preventing or Treating Inflammation, Allergy and Atopic Dermatitis and the Use Thereof | Yuran Nam | MOREAU, NASHARA LOUISE | 1655 | Non-Final OA | Apr 14, 2023 |
| 18031902 | PROCESS FOR THE PRODUCTION OF 21-(ACETYLOXY)-17-(PROPIONYLOXY)-PREGN-4-ENE-3,20-DIONE | Industriale Chimica S.r.l. | MOORE, SUSANNA | 1624 | Non-Final OA | Apr 14, 2023 |
| 18122892 | PROCESSES FOR THE PREPARATION OF SUBSTITUTED SPIROOXINDOLE DERIVATIVES | Enanta Pharmaceuticals, Inc. | COUGHLIN, MATTHEW P | 1626 | Non-Final OA | Mar 17, 2023 |
| 18121097 | Respirable Polynucleotide Powder Formulations for Inhalation | Merz Pharmaceuticals, LLC | ZARA, JANE J | 1637 | Non-Final OA | Mar 14, 2023 |
| 18042589 | SYNTHETIC GROWTH ON ONE-CARBON SUBSTRATES | Mojia Biotech Pte. Ltd. | EPSTEIN, TODD MATTHEW | 1652 | Non-Final OA | Feb 22, 2023 |
| 18106694 | METHODS AND COMPOSITIONS FOR TREATING COVID INFECTIONS | Decoy Therapeutics Inc. | HELLMAN, KRISTINA M | 1654 | Non-Final OA | Feb 07, 2023 |
| 18019715 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DYSREGULATION | Response Ip Holding Company, LLC | SEITZ, ANTHONY JOSEPH | 1629 | Non-Final OA | Feb 03, 2023 |
| 18102254 | METHOD FOR REMOVING ACIDS FROM ORGANIC SOLVENTS | Nanoscale Components, Inc. | KOLTONOW, ANDREW ROBERT | 1795 | Non-Final OA | Jan 27, 2023 |
| 18148942 | SERPIN PEPTIDES AND METHODS OF USING THE SAME | Serpin Pharma, LLC | DEVI, SARVAMANGALA | 1645 | Final Rejection | Dec 30, 2022 |
| 18081431 | AGRICULTURAL COMPOSITIONS COMPRISING MICROBIAL CONSORTIA, AND METHODS OF USE THEREOF | Microbes, Inc. | TICHY, JENNIFER M.H. | 1653 | Final Rejection | Dec 14, 2022 |
| 18080114 | Systems And Methods For Carbon Dioxide Conversion | Carbogenesis LLC | TAI, XIUYU | 1795 | Non-Final OA | Dec 13, 2022 |
| 18079952 | SYSTEMS AND METHODS FOR SELECTIVE REDOX REACTIONS | Soane Labs, LLC | LEE, JOHN | 1794 | Non-Final OA | Dec 13, 2022 |
| 18080023 | Systems and Methods for Nitrogen Fixation | Soane Technologies, LLC | LI, JUN | 1732 | Non-Final OA | Dec 13, 2022 |
| 17989103 | SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS | Enanta Pharmaceuticals, Inc. | MOORE, SUSANNA | 1624 | Non-Final OA | Nov 17, 2022 |
| 17967888 | FMRP AND CANCER TREATMENT | ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE | WHITEMAN, BRIAN A | 1636 | Final Rejection | Oct 17, 2022 |
| 17951891 | PHASED INTRODUCTION OF LITHIUM INTO THE PRE-LITHIATED ANODE OF A LITHIUM ION ELECTROCHEMICAL CELL | Nanoscale Components, Inc. | CHAN, HENG M | 1725 | Non-Final OA | Sep 23, 2022 |
| 17949562 | NONTOXIC COATING CONCENTRATES FOR AGRICULTURAL USES | Crop Enhancement, Inc. | JOHNSON, DANIELLE D | 1617 | Non-Final OA | Sep 21, 2022 |
| 17892436 | SURFACTANT FORMULATIONS FOR INHALATION | Merz Pharmaceuticals, LLC | HELM, CARALYNNE E | 1615 | Non-Final OA | Aug 22, 2022 |
| 17796904 | XANTHAN-BASED OPHTHALMIC TOPICAL FORMULATIONS WITH A REDUCED DOSAGE REGIMEN | Sifi S.p.A. | CREWS, JARET JAMES | 1691 | Final Rejection | Aug 02, 2022 |
| 17781168 | METHOD FOR THE DETERMINATION OF SODIUM HYALURONATE CONTENT IN A HYDROGEL | UB-CARE S.R.L. | SIMMONS, VALERIE MICHELLE | 1758 | Final Rejection | May 31, 2022 |
| 17779709 | METHODS EMPLOYING GASEOUS NITRIC OXIDE FOR INHIBITING TUMOR GROWTH | Beyond Air, Inc. | UNDERDAHL, THANE E | 1699 | Non-Final OA | May 25, 2022 |
| 17584663 | RAPID RELIEF OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE | Merz Pharmaceuticals, LLC | HASTINGS, ALISON AZAR | 1627 | Final Rejection | Jan 26, 2022 |
| 17623331 | APPLICATION OF PROGESTIN IN PREPARATION OF DRUG INHIBITING CYTOKINE STORM | Shenzhen Evergreen Therapeutics Co., Ltd. | DAHLIN, HEATHER RAQUEL | 1629 | Final Rejection | Dec 28, 2021 |
| 17527965 | NOVEL DRUG DELIVERY COMPOSITION AND PROCESS FOR BLOOD-BRAIN BARRIER CROSSING | Cytodigm, Inc. | MACH, ANDRE | 1615 | Non-Final OA | Nov 16, 2021 |
| 17610979 | AEROGEL- AND/OR XEROGEL-BASED MASS FOR ADVANCED MANUFACTURING AND USE THEREOF | ETH ZÜRICH | VO, HAI | 1788 | Non-Final OA | Nov 12, 2021 |
| 17519119 | PULMONARY PHARMACEUTICAL FORMULATIONS | Merz Pharmaceuticals, LLC | ATKINSON, JOSHUA ALEXANDER | 1612 | Non-Final OA | Nov 04, 2021 |
| 17501142 | Compositions and Methods for Treating or Preventing Gut Permeability-Related Disorders | Gelesis LLC | SONG, JIANFENG | 1613 | Non-Final OA | Oct 14, 2021 |
| 17478293 | ANTISENSE OLIGONUCLEOTIDES FOR ALLELE SPECIFICITY | Arnay Sciences LLC | SULLIVAN, STEPHANIE LAUREN | 1635 | Non-Final OA | Sep 17, 2021 |
| 16627382 | Balloon Stent | LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. | OU, JING RUI | 3771 | Non-Final OA | Dec 30, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial